Rachna Patel
Medical · Dallas, TXNPI 1962736355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by GSK at 34.7% of the total.
Across 174 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$470
- Novo Nordisk$350
- AbbVie$219
- Amgen$193
- Lilly USA, LLC$121
- plus $758 from 16 others
What the payments were for
- Food & beverage$3,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 56 | $1,122 |
| AstraZeneca | 24 | $470 |
| Novo Nordisk | 21 | $350 |
| AbbVie | 14 | $219 |
| Amgen | 9 | $193 |
| Lilly USA, LLC | 8 | $121 |
| Sanofi-aventis U.S. LLC | 6 | $95 |
| Abbott | 6 | $94 |
| Amarin Pharma, Inc. | 4 | $91 |
| Boehringer Ingelheim | 4 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $81 |
| Dexcom, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $43 |
| Exact Sciences | 2 | $42 |
| Merck | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Antares Pharma, Inc. | 1 | $12 |
How this compares
$3,233 in reported general payments places this provider in the 75th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $474 |
| Atorvastatin Calcium | 40 | $196 |
| Montelukast Sodium | 14 | $119 |
| Losartan Potassium | 13 | $112 |
| Rosuvastatin Calcium | 29 | $110 |
| Alendronate Sodium | 12 | $77 |
| Levothyroxine Sodium | 15 | $72 |
| Pantoprazole Sodium | 13 | $48 |
| Amlodipine Besylate | 22 | $19 |
| Hydrochlorothiazide | 11 | $2 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Shakira CabreraSan Antonio$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.